TherapeuticsMD reported 523K in Cash and Equivalent for its fiscal quarter ending in June of 2024.





Cash And Equivalent Change Date
AbbVie USD 6.57B 2.82B Jun/2026
Alterity Therapeutics Limited AUD 15.77M 9.56M Jun/2023
Cipla INR 10.18B 2.22B Mar/2026
Clal Biotechnology ILS 5.73M 1.71M Dec/2023
Compugen USD 12.43M 78.16M Mar/2026
CSL USD 2.16B 633M Jun/2025
Grifols EUR 979.78M 334.84M Dec/2024
Novo Nordisk DKK 21.13B 17.81B Mar/2026
Pfizer USD 976M 727M Jun/2026
TherapeuticsMD 523K 89K Jun/2024